Gastrointestinal Radiology: Page 115

Viatronix completes Massachusetts installations
By AuntMinnie.com staff writers
Advanced visualization firm Viatronix of Stony Brook, NY, has installed its V3D Colon module at Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) in Boston, as well as the BWH Radiology outpatient imaging center in Chestnut Hill, MA.
February 28, 2007
Lossy 3D JPEG 2000 compression useful for abdominal MDCT
By Erik L. Ridley
Lossy 3D JPEG 2000-compressed abdominal multidetector-row CT (MDCT) studies are visually indistinguishable from the original studies at ratios of 4:1 and 8:1, according to research from the Medical University of Vienna in Austria.
February 22, 2007
Double dose of oral sodium phosphate unnecessary for VC
By Eric Barnes
In virtual colonoscopy, the double-dose (90 mL) sodium phosphate bowel cleansing regimen, despite its proven effectiveness, may be too much of a good thing, according to researchers from the University of Wisconsin in Madison. The group compared the 90 mL (double) sodium phosphate cleansing regimen against that of a 45 mL (single) regimen, and found the single dose to be as effective as the double-dose regimen.
February 18, 2007
Medicsight lands Canadian licenses
By AuntMinnie.com staff writers
Computer-aided detection (CAD) developer Medicsight has received medical device licenses from the Therapeutic Products Directorate (TPD) of Health Canada.
February 13, 2007
MR colonography reveals significant extracolonic findings
By Eric Barnes
MRI has joined the parade of extracolonic findings detected at virtual colonoscopy, in a study of 375 symptomatic individuals in Germany. In evaluating dark-lumen MR colonography (MRC) for assessing extracolonic organs, researchers from University Hospital Essen found clinically significant findings in 12% of their cohort.
February 13, 2007
External anal sphincter defect findings nearly equivalent on MR, US
By Jonathan S. Batchelor
Endoanal MRI and endoanal ultrasound demonstrate nearly equal capabilities for depicting external anal sphincter (EAS) defects in patients with fecal incontinence. A four-year, multicenter study from the Netherlands has found that both modalities are sensitive tools for preoperative assessment and both techniques can be used to depict surgically repairable anterior EAS defects.
February 6, 2007
2007 02 06 16 33 40 706
VC CAD delivers accuracy on unfamiliar datasets
By Eric Barnes
The National Institutes of Health tested its virtual colonoscopy computer-aided detection (CAD) system on a patient cohort it wasn't trained on, garnering high marks for sensitivity and specificity in a sizeable study. Fortunately it found all the cancers, too.
February 4, 2007
2007 02 05 12 25 36 706
Study: PET accurate for newborns' pancreatic defects
By AuntMinnie.com staff writers
Positron emission tomography (PET) is extremely accurate in diagnosing a type of congenital hyperinsulinism (HI), a rare but severe imbalance of insulin levels in newborns.
January 29, 2007
Ablation for local HCC treatment on the rise, study finds
The use of ablation techniques for primary liver cancer treatment has increased steadily over the first part of the 21st century, according to a presentation last week at the 2007 Gastrointestinal Cancers Symposium in Orlando, FL, sponsored by the American Society of Clinical Oncology (ASCO).
January 29, 2007
Gastroenterologists plan to perform VC
By Eric Barnes
A recent report by the American Gastroenterological Association (AGA) outlines plans for gastroenterology practices to not only incorporate virtual colonoscopy into colon cancer screening, but bypass radiologists entirely to scan patients on their own. Leading gastroenterologists and radiologists weigh in on the report.
January 24, 2007
Cook donates $2 million to Baptist-Miami
By AuntMinnie.com staff writers
Interventional firm Cook has donated $2 million to the Baptist Cardiac & Vascular Institute Foundation in Miami to establish the Barry T. Katzen Medical Director Endowment Fund at the facility.
January 17, 2007
Neoprobe gets FDA nod for more Lymphoseek trials
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe has received authorization from the U.S. Food and Drug Administration (FDA) to begin patient enrollment in two phase I clinical studies for its Lymphoseek targeting agent.
January 16, 2007
Previous Page
Page 115 of 170
Next Page